New research shows an AI-powered chatbot trained to deliver cognitive behavioral therapy significantly reduced anxiety, ...

After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, ...

Brian Fiske, chief scientist at The Michael J. Fox Foundation for Parkinson’s Research, which funded some of Dr ...

Oncolytic virus therapy is emerging as a low-cost, targeted cancer treatment. With over 60 trials in China, scientists see ...

Ideaya Biosciences (IDYA) announced that the FDA has granted breakthrough therapy designation for darovasertib, a protein kinase C inhibitor, ...

A phase 3 trial plans to further assess neoadjuvant darovasertib for the potential treatment of patients with primary uveal melanoma.

SAN FRANCISCO and SUZHOU, China, March 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that ...

Vision is one of the most crucial human senses, yet over 300 million people worldwide are at risk of vision loss due to ...

ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy ...

An artificial intelligance (AI) chatbot trained by Dartmouth researchers to deliver cognitive behavioral therapy (CBT) significantly reduced depression, anxiety, and eating disorder symptoms.